Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,750 shares at $79.14 ($138K) on 2018-01-16, disclosed to the SEC on 2018-01-18.
Seasonal sale ($138k) by Chief Medical Officer — this insider has traded NBIX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |
| NBIX | SELL | 2017-07-31 | $437K | — | Filing → |